Management of traumatic hyphema

Survey of Ophthalmology

Volumn 47, Issue 4, 2002, Pages 297-334

  Walton, William ^a   Von Hagen, Stanley ^a   Grigorian, Ruben ^a   Zarbin, Marco ^a  

^a INSTITUTE OF OPHTHALMOLOGY AND VISUAL SCIENCE   (United States)

Author keywords

Amicar; Aminocaproic acid; Corneal blood staining; Cyclokapron; Eye trauma; Glaucoma; Hyphema; Optic atrophy; Prednisone; Sickle cell disease; Tranexamic acid

Indexed keywords

ACETYLSALICYLIC ACID; ALCOHOL; AMINOCAPROIC ACID; ANALGESIC AGENT; ANTIFIBRINOLYTIC AGENT; ANTIGLAUCOMA AGENT; ATROPINE; CARBOMER; CONJUGATED ESTROGEN; CYCLOPLEGIC AGENT; DEXAMETHASONE; NONSTEROID ANTIINFLAMMATORY AGENT; PLACEBO; PREDNISONE; PROCHLORPERAZINE; STEROID; TRANEXAMIC ACID; WARFARIN;

ACCOMMODATION PARALYSIS; ADHESION; BLEEDING; BLOOD STAIN; BLUNT TRAUMA; CLINICAL TRIAL; DISEASE ASSOCIATION; DISEASE SEVERITY; EYE SURGERY; FOLLOW UP; GLAUCOMA; HEMOPHILIA; HUMAN; HYPHEMA; IRIS; IRIS RUBEOSIS; JUVENILE XANTHOGRANULOMA; LACERATION; LEUKEMIA; MELANOMA; MOBILIZATION; NAUSEA; OPTIC NERVE ATROPHY; ORTHOSTATIC HYPOTENSION; PATIENT COMPLIANCE; PRIORITY JOURNAL; REVIEW; SICKLE CELL ANEMIA; SIDE EFFECT; TREATMENT OUTCOME; UVEITIS; VARICELLA ZOSTER VIRUS; VERTIGO; VOMITING; VON WILLEBRAND DISEASE;

ADRENAL CORTEX HORMONES; AMBULATORY CARE; ANEMIA, SICKLE CELL; ANTERIOR CHAMBER; ANTIFIBRINOLYTIC AGENTS; BED REST; CORNEAL DISEASES; HUMANS; HYPHEMA; META-ANALYSIS; OCULAR HYPERTENSION; PIGMENTATION DISORDERS; RECURRENCE; TREATMENT OUTCOME; WOUNDS, NONPENETRATING;

EID: 0036345775     PISSN: 00396257     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0039-6257(02)00317-X     Document Type: Review

References (219)

1. Mechanism of clot lysis by streptokinase and effects of epsilon-aminocaproic acid
2. Inhibition of plasmin, trypsin and the streptokinase-activated fibrinolytic system by epsilon-aminocaproic acid
3. Spontaneous massive vitreous hemorrhage secondary to thrombocytopenia
4. Traumatic hyphema in children
5. Herpes zoster sine herpete presenting with hyphema
6. E-aminocaproic acid: An inhibitor of plasminogen activation
7. Topical aminocaproic acid significantly reduces the incidence of secondary hemorrhage in traumatic hyphema in the rabbit model
8. Topically applied aminocaproic acid concentrates in the aqueous humor of the rabbit in therapeutic levels
9. Contusion angle deformity and glaucoma
10. Melanoma of the iris: Report of 72 cases treated surgically
11. Meta-analysis of systemic anti-fibrinolytics in traumatic hyphaema
12. The effects of the carbonic anhydrase inhibitor, acetazolamide, on the composition of the aqueous humor
13. The management of traumatic hyphema
14. Leukemic iris infiltration as the only site of relapse in a child with acute lymphoblastic leukemia: Temporary remission with high-dose chemotherapy
15. Treatment of traumatic hyphaema
16. Corneal blood staining at low pressures
17. Vascular tufts of the pupillary border causing a spontaneous hyphaema
18. Therapy of open angle glaucoma
19. Traumatic hyphema in children
20. No statistically significant difference. So what?
21. Fibrinolysis and traumatic hyphaema
22. Traumatic eye hemorrhage (hyphema) treated with the antifibrinolytic preparation tranexamic acid
23. Traumatic hyphaema treated with the antifibrinolytic drug tranexamic acid II
24. Recurrent hemorrhage in the anterior chamber caused by a (juvenile) xanthogranuloma of the iris in an adult
25. Rhabdomyolysis during treatment with epsilon-aminocaproic acid
26. Follow-up of 54 cases of ocular contusion with hyphema
27. Myoglobinuria following epsilon-aminocaproic acid (EACA) therapy. Case report
28. Corneal blood staining after hyphaema
29. Presumed juvenile xanthogranuloma of the iris and ciliary body in an adult
30. Factors of importance in traumatic hyphema with particular reference to and study of routes of absorption
31. Ghost cell glaucoma following trauma
32. Ghost cells as a cause of glaucoma
33. Anterior segment consequences of blunt ocular injury
34. Wills Eye Hospital Traumatic Hyphema Study
35. Factors associated with poor visual outcome after traumatic hyphema
36. Outpatient treatment of microscopic and rim hyphemas in children with tranexamic acid
37. Home care of hyphemas
38. Unrecognized microscopic hyphema masquerading as a closed head injury
39. Outpatient management of traumatic hyphemas in children
40. Vascular tufts at the pupillary margin in myotonic dystrophy
41. Diagnosis and management of ocular complications of sickle hemoglobinopathies: Part V
42. Evaluation of 100 eyes with traumatic hyphema: Intravenous urea
43. Vascular tufts of pupillary margin of iris
44. Traumatic hyphema: An analysis of 235 cases
45. The effect of aspirin on rebleeding in traumatic hyphema
46. Management of traumatic hyphema: Therapeutic options
47. Aminocaproic acid in the treatment of traumatic hyphema
48. Trauma: Ruptures and bleeding
49. Topical aminocaproic acid in the treatment of traumatic hyphema
50. Management of traumatic hyphema
51. Effect of epsilon-aminocaproic acid on postvitrectomy hemorrhage
52. Oral administration of tranexamic acid in the management of traumatic hyphema in children
53. A survey of severe eye injuries in children
54. Indications for surgical management of hyphema in patients with sickle cell trait
55. Total hyphema evacuation by vitrectomy instrumentation
56. Intraocular pressure increase associated with epsilon-aminocaproic acid therapy for traumatic hyphema
57. Airbag-associated bilateral hyphemas and angle recession
58. Ocular damage after blunt trauma to the eye. Its relationship to the nature of the injury
59. Refereeing clinical research papers for statistical content
60. Kaolin partial thromboplastin time: High levels of procoagulants producing short clotting times or masking deficiencies of other procoagulants or low concentrations of anticoagulants
61. Traumatic hyphema. A report of 184 consecutive cases
62. Factors affecting therapeutic concentration of topical aminocaproic acid in traumatic hyphema
63. Aminocaproic acid versus prednisone for the treatment of traumatic hyphema. A randomized clinical trial
64. Traumatic hyphema: Preliminary report on 200 cases
65. Pathophysiologic aspects of sickle cell anemia
66. Secondary hemorrhage in traumatic hyphema. Predictive factors for selective prophylaxis
67. Traumatic hyphema
68. Traumatic hyphema: A review of experience at the Medical College of Virginia during the past decade
69. Atropine in the treatment of traumatic hyphema
70. Treatment and prophylaxis of hyphaema by conjugated estrogens
71. Conjugated estrogens in the prevention of secondary hyphema after ocular trauma
72. The diagnosis and treatment of secondary glaucoma after hyphema in sickle cell patients
73. The diagnosis and treatment of sickled erythrocytes in human hyphemas
74. Sickled erythrocytes, hyphema, and secondary glaucoma: VI. The relationship between intracameral blood cells and aqueous humor pH, PO2, and PCO2
75. Sickled erythrocytes, hyphema and secondary glaucoma: III. Effects of sickle cell and normal human blood samples in rabbit anterior chambers
76. Sickled erythrocytes, hyphema, and secondary glaucoma: VII. The passage of sickled erythrocytes out of the anterior chamber of the human and monkey eye: Light and electron microscopic studies
77. The detrimental effect of aspirin on hyphema rebleed
78. Hyphema: Diagnosis and management
79. Protoporphyrin IX photosensitization of corneal endothelium
80. Corneal blood staining. An animal model
81. Trabeculectomy for traumatic hyphema with increased intraocular pressure
82. Traumatic hyphema II
83. Traumatic hyphema I
84. Epsilon-aminocaproic acid (EACA)
85. Changes in coagulation and fibrinolysis in patients with sickle cell disease compared with healthy black controls
86. Pitfalls in the management of a child with mild haemophilia A and a traumatic hyphaema
87. Nonperforating eye injuries with hyphema
88. Erythrocyte resorption from the anterior chamber of the human eye
89. Hyphema resulting from blunt trauma - Gonioscopic, tonographic, and ophthalmoscopic observation following resolution of the hemorrhage
90. Intraocular tissue plasminogen activator in a rabbit model of traumatic hyphema
91. Intraocular hemorrhage from wound neovascularization years after anterior segment surgery (Swan syndrome)
92. Spontaneous hyphema associated with ingestion of aspirin and ethanol
93. An analytical electron microscopic study of the corneal and conjunctival deposits of pigments and other substances. Part 4: Hematogenous pigmentation
94. Glaucoma after traumatic angle recession. A ten-year prospective study
95. Traumatic hyphaema: A retrospective study of 314 cases
96. Traumatic hyphema in a defined population
97. Treatment of total hyphema with relatively low-dose tissue plasminogen activator
98. Management of traumatic hyphema with glaucoma
99. Intraocular hemorrhage in a patient with hemophilia
100. Spontaneous hyphema resulting from warfarin
101. Traumatic hyphema in children. Treatment with epsilon-aminocaproic acid
102. Spontaneous hyphema and acute glaucoma as initial signs of recurrent iris melanoma
103. Traumatic hyphema
104. The use and abuse of statistics
105. Aminocaproic acid reduces the risk of secondary hemorrhage in patients with traumatic hyphema
106. The use of tissue plasminogen activator in post-traumatic total hyphaema
107. Traumatic hyphema in children: Risk factors for complications
108. Effect of melanin on traumatic hyphema in rabbits
109. Use of tissue plasminogen activator in experimental hyphema
110. Aqueous humor flow in human eyes treated with dorzolamide and different doses of acetazolamide
111. Anterior chamber hemorrhage in nonperforating injuries
112. The incidence of secondary hemorrhage after traumatic hyphema
113. Treatment of total hyphemas with urokinase
114. Traumatic hyphema in children
115. Traumatic total hyphema in a patient with severe hemophilia
116. The medical management of traumatic hyphaema: A survey of opinion among ophthalmologists in the UK
117. Systemic aminocaproic acid reduces fibrinolysis in aqueous humor
118. Traumatic hyphema
119. Myopathy associated with epsilon-aminocaproic acid (EACA) therapy. Report of two cases
120. Recurrent microhyphema in the pseudophakic eye
121. Blood staining of the cornea
122. Aspirin and secondary bleeding after traumatic hyphema
123. The use of permeability studies in the investigation of submicroscopic structure
124. The role of vitrectomy instrumentation in the treatment of severe traumatic hyphema
125. Medical and surgical management of spontaneous hyphaema secondary to immune thrombocytopenia
126. Blood staining of the cornea. Light microscopic and ultrastructural features
127. Aminocaproic acid decreases secondary hemorrhage after traumatic hyphema
128. The absorption, distribution and excretion of e-aminocaproic acid following oral or intravenous administration
129. Blood staining of the cornea: A histopathologic analysis of 16 cases
130. Bimanual bipolar diathermy for treatment of bleeding from the anterior chamber angle
131. Retinal arterial occlusion following ocular trauma in youths with sickle-trait hemoglobinopathy
132. Serious ocular complications associated with blowout fractures of the orbit
133. Hyphema caused by airbag
134. The value of tranexamic acid (cyklokapron) in the prevention of secondary bleeding, a complication of traumatic hyphaemia
135. Angle recession and secondary glaucoma
136. Traumatic hyphaema in a haemophiliac
137. Secondary haemorrhage following traumatic hyphaema. A comparative study of conservative and tranexamic acid treatment
138. Sickle cell trait as a risk factor for secondary hemorrhage in children with traumatic hyphema
139. Factors related to the final visual outcome of 425 patients with traumatic hyphema
140. Factors related to the incidence of secondary haemorrhage in 462 patients with traumatic hyphema
141. Occult iris erosion. A treatable cause of recurrent hyphema in iris- supported intraocular lenses
142. Treatment of traumatic hyphaema with corticosteroids and mydriatics
143. A suppressing effect of epsilon aminocaproic acid to cross the blood brain barrier and reduce the spinal fluid fibrinolytic activity
144. Treatment of traumatic hyphaema
145. The effect of timolol on anterior-chamber oxygenation
146. A comparison of two dose regimens of epsilon aminocaproic acid in the prevention and management of secondary traumatic hyphemas
147. On intraocular fibrinolysis
148. Retinal artery occlusion associated with tranexamic acid therapy
149. Topical aminocaproic acid (Caprogel) in the treatment of traumatic hyphema: Results of a phase III multicenter placebo controlled trial
150. Acute renal failure due to high-grade obstruction following therapy with epsilon-aminocaproic acid
151. Ultrastructure of a hematocornea
152. Central retinal artery occlusion (reversible in sickle trait) with glaucoma
153. Comparison of tranexamic acid and prednisolone in the treatment of traumatic hyphema. A randomized clinical trial
154. An analysis of risk for secondary hemorrhage in traumatic hyphema
155. Traumatic hyphema
156. Traumatic hyphema: Surgical vs medical management
157. Comparison of medical treatment for traumatic hyphema
158. Traumatic hyphema management: Assuring compliance with outpatient care; Steroidophobia: Rational or irrational?
159. Systemic prednisolone prevents rebleeding in traumatic hyphema
160. Pro steroids for systemic antifibrinolytic treatment for traumatic hyphema
161. Management of traumatic hyphema
162. The effect of age and ethnic background on the natural rebleed rate in untreated traumatic hyphema in children
163. Traumatic hyphema: A critical review of the scientifically catastrophic history of steroid treatment therefore; And A report of 24 additional cases with no rebleeding after treatment with the Yasuna systemic steroid, no touch PLUS protocol
164. Traumatic hyphema: A comprehensive review of the past half century yields 8076 cases for which specific medical treatment reduces rebleeding 62%, from 13% to 5% (p < .0001)
165. Systemic corticosteroids in the treatment of traumatic hyphema
166. Treatment of total hyphema with fibrinolysin
167. Coumadin related spontaneous hyphemas in patients with iris fixated pseudophakos
168. Surgical management of black ball hyphema
169. Outcome of traumatic hyphema
170. Argon laser therapy of occult recurrent hyphema from anterior segment wound neovascularization
171. Traumatic hyphema in children
172. Traumatic hyphema: Outcomes of outpatient management
173. Traumatic hyphaema treated ambulatory and without antifibrinolytic drugs
174. Recurrent hemorrhage in traumatic hyphema
175. Anterior chamber hemorrhages following nonperforating ocular injuries
176. Central venous stasis retinopathy following the use of tranexamic acid
177. Traumatic central retinal artery occlusion with sickle cell trait
178. Traumatic hyphema: Its clinical characteristics and failure of estrogens to alter its course. A double-blind study
179. Recurrent hyphema after surgery
180. Traumatic hyphema. Failure of steroids to alter its course: A double- blind prospective study
181. Traumatic hyphema in an urban population
182. Low-dose intraocular tissue plasminogen activator treatment for traumatic total hyphema, postcataract, and penetrating keratoplasty fibrinous membranes
183. Vitrectomy instrumentation for surgical evacuation of total anterior chamber hyphema and control of recurrent anterior chamber hemorrhage
184. Late hyphema due to wound vascularization
185. Hyphema due to wound vascularization after cataract extraction
186. Clinical evaluation of aminocaproic acid for managing traumatic hyphema in children
187. Incidence of accommodative impairment following traumatic hyphema
188. Rebleeding after traumatic hyphema
189. Observations in traumatic hyphema
190. Intraocular pressure and facility of outflow late after ocular contusion
191. Gonioscopy in traumatic hyphema
192. Management of traumatic hyphema in children. An analysis of 340 cases
193. Tranexamic acid in the prevention of secondary haemorrhage after traumatic hyphaema
194. Tranexamic acid and traumatic hyphaema. A prospective study
195. The effect of tranexamic acid on secondary haemorrhage after traumatic hyphaema
196. Trabeculectomy and manual clot evacuation in traumatic hyphaema with corneal blood staining
197. Effects of topical epinephrine on experimental sickle cell hyphema
198. Secondary hemorrhage in traumatic hyphema
199. Intraocular hemorrhage from vascularization of the cataract incision
200. Reversal of retinal and optic disc ischemia in a patient with sickle cell trait and glaucoma secondary to traumatic hyphema
201. Surgical therapy of traumatic hyphema
202. Four-week safety and efficacy study of dorzolamide, a novel, active topical carbonic anhydrase inhibitor
203. Outpatient management of small traumatic hyphaemas: Is it safe?
204. Rebleeding in experimental traumatic hyphema treated with intraocular tissue plasminogen activator
205. Traumatic hyphema. Pathogenesis and management
206. Aminocaproic acid prophylaxis in traumatic hyphema
207. Outpatient management of traumatic microhyphemas
208. The incidence of rebleeding in traumatic hyphema
209. Histopathology of a black ball blood clot removed four days after total traumatic hyphema
210. Bed rest versus activity ad lib in the treatment of small hyphemas
211. Management of traumatic hyphema
212. Blood staining of the cornea in Hansens disease. A light- and electron- microscopic study
213. The treatment of contusion of the eye